In premenopausal women with hormone-sensitive breast cancer, drugs that stop the ovaries from functioning — thus shutting off the body's main source of the hormone estrogen — reduced the rates of relapse and of death following relapse when given in addition to tamoxifen, chemotherapy, or both.